San Diego, CA, United States of America

Kelly D Hester

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignee: Nestec S.a.. Active years: 2017.

USPTO Granted Patents = 1 

 

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kelly D Hester: Innovator in Leukocyte and Tumor Cell Isolation

Introduction

Kelly D Hester is a prominent inventor based in San Diego, CA. She has made significant contributions to the field of medical technology, particularly in the isolation of blood cells. Her innovative work focuses on improving methods for recovering leukocytes and tumor cells, which are crucial for various medical applications.

Latest Patents

Kelly D Hester holds a patent for an "Apparatus and method for isolating leukocytes and tumor cells by filtration." This invention provides novel apparatuses and methods for isolating or recovering a subset of blood cells, such as leukocytes and circulating tumor cells, from blood samples by filtration. Importantly, her method does not alter the intracellular concentration of therapeutic agents, such as anticancer drugs. This advancement allows for the recovery of cell lysates from leukocytes and tumor cells without substantial dilution of these critical therapeutic agents.

Career Highlights

Kelly is currently employed at Nestec S.A., where she continues to develop innovative solutions in the medical field. Her work has garnered attention for its potential to enhance cancer treatment methodologies and improve patient outcomes.

Collaborations

Throughout her career, Kelly has collaborated with notable colleagues, including Sharat Singh and Xinjun Liu. These partnerships have contributed to the advancement of her research and the successful development of her patented technologies.

Conclusion

Kelly D Hester is a trailblazer in the field of medical technology, with her innovative patent addressing critical challenges in the isolation of blood cells. Her contributions are poised to make a significant impact on cancer treatment and patient care.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…